Silvant Capital Management LLC Makes New Investment in Astera Labs, Inc. $ALAB

Silvant Capital Management LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 23,347 shares of the company’s stock, valued at approximately $11,277,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in Astera Labs in the second quarter valued at $6,609,581,000. Atreides Management LP grew its stake in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi increased its holdings in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership acquired a new position in Astera Labs in the fourth quarter valued at approximately $148,980,000. Finally, Goldman Sachs Group Inc. lifted its stake in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after buying an additional 858,693 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director directly owned 4,631 shares in the company, valued at approximately $2,083,950. This trade represents a 66.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 419,244 shares of company stock worth $163,135,169 over the last quarter. Company insiders own 10.40% of the company’s stock.

Astera Labs Trading Up 0.5%

Shares of NASDAQ ALAB opened at $290.52 on Friday. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market capitalization of $50.40 billion, a price-to-earnings ratio of 143.82 and a beta of 3.84. The business has a 50-day moving average of $354.34 and a 200-day moving average of $244.64.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Scorpio growth is becoming the key catalyst: Analysts expect Scorpio to overtake Aries as Astera Labs’ largest product family, increasing the company’s semiconductor content per AI accelerator. Third-quarter revenue guidance implies approximately 40% sequential growth to about $550 million, while operating margins are expected to approach 43%. Astera Labs: Scorpio Is Becoming The Real Story
• Positive Sentiment: AI connectivity demand remains strong: Recent coverage points to record demand for Astera’s data-center connectivity products as hyperscalers and other customers expand AI infrastructure. The company’s latest quarter showed revenue growth of 104.5% year over year to $392.4 million, while EPS exceeded consensus estimates. Astera Labs stock in focus on record AI-connectivity demand
• Positive Sentiment: Analyst sentiment improved: Northland Securities upgraded ALAB to “Outperform.” MarketBeat reports a “Moderate Buy” consensus rating and an average price target of $333, while other analysts have raised targets following the company’s earnings report. Northland Securities Upgrades Astera Labs to Outperform
• Positive Sentiment: Strong relative growth profile: Comparisons with Credo and monday.com emphasize Astera’s accelerating quarterly revenue trajectory and exposure to AI connectivity, though investors should remember these are opinion-based comparisons rather than new company guidance. Credo vs. Astera Labs: Which AI Connectivity Stock Is the Better Buy?
• Neutral Sentiment: Insider sales were tax-related: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares totaling roughly $64 million. The filings state the transactions covered tax withholding from vested equity awards, and each executive retained a substantial position; nevertheless, the sales could weigh on short-term sentiment. SEC insider transaction filing
• Negative Sentiment: Valuation and technical pressure remain risks: Astera trades at a price-to-earnings ratio above 140 and below its 50-day moving average. With a beta near 3.8, the stock is particularly sensitive to profit-taking and shifts in AI-sector sentiment after its sharp prior rally.

Analysts Set New Price Targets

A number of research firms have issued reports on ALAB. Citigroup restated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Susquehanna increased their price target on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. UBS Group reaffirmed a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Stifel Nicolaus boosted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.